Active Ingredient(s): Docosanol
FDA Approved: * July 25, 2000
Category: Antiviral

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Abreva Overview

1-Docosanol, also known as behenyl alcohol, is a saturated fatty alcohol containing 22 carbon atoms, used traditionally as an emollient, emulsifier, and thickener in cosmetics,[3] and nutritional supplement (as an individual entity and also as a constituent of policosanol).[citation needed] More recently, docosanol has been approved by the Food and Drug Administration (FDA) as a pharmaceutical antiviral agent[4] for reducing the duration of cold...

Read more Abreva Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Docosanol

Recent Abreva Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Cream: 10%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Abreva: (3 results)

Sorted by National Drug Code
  • 0135-0200 Abreva 100 mg/g Topical Cream by Glaxosmithkline Consumer Healthcare Lp
  • 50090-3476 Abreva 100 mg/g Topical Cream by A-s Medication Solutions
  • 63379-056 Abreva 100 mg/g Topical Cream by Glaxo Operations Uk Ltd

Other drugs which contain Docosanol or a similar ingredient: (2 results)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 4 August 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA